DallasTexas
ADVANCED THERAPIES WEEK 2025 DALLAS
Welcome to the press portal for Advanced Therapies Week, the first one in Dallas - January 20th - 24th 2024 - KAY BAILEY HUTCHISON CONVENTION CENTER DALLAS
For ATW25 - here you can find all the latest news direct from the conference; press releases, interviews from the floor, blog and video updates. Make sure to check in regularly.
We have a great list of media covering the show. Feel free to connect with the IB team if you are a journalist or exhibitor and require any assistance during the show.
Advanced Therapies Week is an event like no other. With networking opportunities taking place from morning to night, we provide attendees with an outstanding experience that entails thought-provoking content, high-profile speakers, and unmissable networking events.
IB Communications is the leading international communications agency in the CGT space. We hold specific expertise in the biotech and biopharma sectors and mid-size pharma.
Press office contact: phacilitate@ibcomms.agency / +44 (0) 7707 560846 or +1 857 313 4628
Scroll down for latest news and press releases...
IB Communications is a leading international communications agency specialising in healthcare and life sciences. We hold specific expertise in the biotech and biopharma sectors, including immunotherapy, regenerative medicine, ATMPs and cell and gene therapy.
Press office contact: phacilitate@ibcomms.agency / +44 (0) 7707 560846 or +1 857 313 4628
Reaction from around the show
Content will be posted as its created and available
Please contact us if you believe there are mistakes in these videos - we'll do our best to rectify them ASAP
2025 Advanced Therapies Week - Press Releases
Charles River Introduces Global Biotech Incubator Program
WILMINGTON, Mass.--(BUSINESS WIRE)--Dec. 5, 2024-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of the Charles River Incubator Program (CIP), specializing in supporting early-stage biotechnology companies in the discovery, development and phase- appropriate manufacturing of advanced therapies.
Innovative Cell Expansion System Enables Real-Time Metabolic Monitoring and Automated Culture Optimization to Accelerate Cell and Gene Therapy Manufacturing
(Wood Dale, IL, December 10, 2024) PHC Corporation of North America (PHCNA), supplier of the PHCbi brand of cell preservation and growth products in North America and Latin America, will showcase a prototype of its cell expansion system LiCellGrow at Advanced Therapies Week in Dallas, Texas in January. View here
BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
MINNEAPOLIS, Jan. 8, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPakTM GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy development and manufacturing at Phacilitate's Advanced Therapies Week, taking place January 20-23 at the Kay Bailey Hutchison Convention Center in Dallas, Texas.. View here
BBG Advanced Therapies to begin service Jan. 1
SAN ANTONIO, Texas – Building on its 50-year history of saving and enhancing lives through the healing power of human cells and tissue, BioBridge Global announced today that it is consolidating its end-to-end Cell and Gene Therapy Services portfolio into a new, highly integrated and coordinated operating subsidiary, BBG Advanced Therapies.
Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific Collaborate to Accelerate T Cell Expansion for Cell Therapy Developers 5
Lakewood, COLO. AND SANTA ANA, CALIF., January 14, 2025 – Terumo Blood and Cell Technologies (Terumo BCT), and FUJIFILM Irvine Scientific have announced a strategic collaboration to help accelerate T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System. View here
Blood and Cells Advocacy Roster (BCAR) Launches to Provide Joint Voice for the Blood Industry
Wyoming, US, December 11, 2024 – The Blood and Cells Advocacy Roster (BCAR), an industry consortium of blood therapy and cell and gene therapy starting materials stakeholders, launches today to function as a think-tank plus speaker advocacy group. The international organization aims to drive
Emerson Wins 2025 IoT Breakthrough Award for ‘Industrial Innovation of the Year’
AUSTIN (Jan. 8, 2025) – Emerson (NYSE: EMR), an industrial technology leader delivering advanced automation solutions, has won the “Industrial IoT Innovation of the Year” award for its DeltaV™ Workflow Management software....
Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference
DALLAS, Jan. 20, 2025 — Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative diseases...
Cardinal Health highlights cell & gene “white glove delivery” solutions at Advanced Therapies Week 2025
DUBLIN, Ohio – Jan.16, 2025 – Cardinal Health™ Nuclear & Precision Health Solutions
(NPHS) will attend Advanced Therapies Week 2025 in Dallas, TX, January 20-23, 2025, and
feature its cell & gene white glove delivery capabilities.
SCTbio and CCRM Nordic Form Strategic Partnership to Accelerate Advanced Therapy Development
SCTbio, a leading provider of cGMP manufacturing services for cell-based products, today announced a strategic partnership with CCRM Nordic,
an organization dedicated to accelerating the commercialization of regenerative medicine technologies and cell and gene therapies.
Reithera and Sillajen Partnership Announced
Rome, Italy January 24th 2025 – ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative anticancer virus platform....
Catalent Announces Collaboration with Galapagos to Further Expand Galapagos’ Decentralized CAR-T Manufacturing Network in the U.S.
January 21 2025 – SOMERSET, NJ – Catalent, Inc., a leader in enabling the development and supply of better treatments for patients worldwide, today announced a strategic collaboration with Galapagos NV (Euronext & NASDAQ: GLPG), a biotechnology company with operations in the U.S. and Europe......
Phacilitate Awards Katherine High with the 2025 Lifetime Achievement Award at the Advanced Therapies Awards Ceremony in Dallas
London, UK, January 22, 2025 – Phacilitate, a leading brand that connects advanced therapies industry leaders through inspiring conferences, vibrant communities and market intelligence, today presented Katherine A. High, M.D. with its prestigious Lifetime Achievement Award for 2025. Dr. High, who is now President of Therapeutics at AskBio, has had a distinguished career....
Whilst every effort is made to ensure data accuracy we acknowledge that mistakes do happen.
If you believe there are corrections required to any of the information contained within these Press Releases, please email: phacilitate@ibcomms.agency.
Images from this years show
"So It's not San Diego but Dallas is one of my favourite cities in the US so Im delighted the shows here. Could be warmer but so far it's been a huge success."
IB Communications Blog
